Get the Stockscreener App
178.83
1.96%
3.43
After Hours:
178.75
-0.08
-0.04%
Overview
News
Price History
Option Chain
Financials
Why HUM Down?
Discussions
Forecast
Dividend History
Humana Inc stock is traded at $178.83, with a volume of 3.32M.
It is up +1.96% in the last 24 hours and down -35.34% over the past month.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
See More
Previous Close:
$175.40
Open:
$172.7
24h Volume:
3.32M
Relative Volume:
1.78
Market Cap:
$21.51B
Revenue:
$126.36B
Net Income/Loss:
$1.30B
P/E Ratio:
16.76
EPS:
10.6697
Net Cash Flow:
$1.55B
1W Performance:
-7.61%
1M Performance:
-35.34%
6M Performance:
-34.96%
1Y Performance:
-31.23%
1-Day Range:
$170.50
$181.79
1-Week Range:
$169.61
$196.75
52-Week Range:
$169.61
$315.35
Humana Inc Stock (HUM) Company Profile
Name
Humana Inc
Sector
Industry
Phone
(502) 580-1000
Address
500 W MAIN ST, LOUISVILLE, KY
Compare HUM vs UNH, CVS, CI, ELV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
178.83 | 21.10B | 126.36B | 1.30B | 1.55B | 10.67 |
|
UNH
Unitedhealth Group Inc
|
284.37 | 252.65B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
77.93 | 97.99B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
CI
Cigna Group
|
287.61 | 77.65B | 216.66B | 6.25B | 7.44B | 22.19 |
|
ELV
Elevance Health Inc
|
336.04 | 72.89B | 199.13B | 5.66B | 3.17B | 25.11 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-02-26 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-07-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-05-25 | Upgrade | Jefferies | Hold → Buy |
| Oct-14-25 | Initiated | Goldman | Sell |
| Sep-22-25 | Initiated | Evercore ISI | In-line |
| May-01-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-06-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Oct-08-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-07-24 | Downgrade | Jefferies | Buy → Hold |
| Oct-07-24 | Downgrade | TD Cowen | Buy → Hold |
| Oct-03-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-02-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-02-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-22-24 | Initiated | Raymond James | Mkt Perform |
| Mar-13-24 | Downgrade | Argus | Buy → Hold |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Jan-26-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-25-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-23 | Upgrade | Argus | Hold → Buy |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-07-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-23-23 | Downgrade | Argus | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Oct-26-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-20-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Initiated | Bernstein | Mkt Perform |
| Apr-13-22 | Upgrade | UBS | Neutral → Buy |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-04-21 | Reiterated | Barclays | Overweight |
| Nov-04-21 | Reiterated | Credit Suisse | Outperform |
| Nov-04-21 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-21 | Reiterated | Oppenheimer | Outperform |
| Nov-04-21 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Sep-09-21 | Resumed | Barclays | Overweight |
| Jul-09-21 | Initiated | Seaport Global Securities | Neutral |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jan-04-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-02-20 | Initiated | Bernstein | Mkt Perform |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-16-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jun-05-20 | Initiated | Goldman | Buy |
| Jan-03-20 | Reiterated | JP Morgan | Overweight |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-12-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Apr-23-19 | Initiated | UBS | Neutral |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-20-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-08-18 | Reiterated | BofA/Merrill | Buy |
| Sep-13-18 | Initiated | Barclays | Overweight |
| Jul-12-18 | Resumed | Morgan Stanley | Overweight |
| Jul-06-18 | Reiterated | Piper Jaffray | Overweight |
| Jun-01-18 | Resumed | Citigroup | Buy |
| Feb-08-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-08-18 | Reiterated | Leerink Partners | Outperform |
| Jan-12-18 | Upgrade | Jefferies | Hold → Buy |
View All
Humana Inc Stock (HUM) Latest News
Renderings for proposed Humana Tower renovations highlighted at mayor's State of the City address - WDRB
Humana (HUM) stock rebounds after earnings shock — Star Ratings and Medicare rates now drive the price - Bez Kabli
Balanced Risk-Reward Amid Growth Ambitions and Margin Rebuild Supports Humana Hold Rating - TipRanks
Humana Is Said to Near $1 Billion Deal for Florida’s MaxHealth - Bloomberg.com
Renderings for Humana Tower renovations highlighted at Greenberg's State of the City Address - WDRB
Humana sells medical office building on Hikes Lane - WDRB
PHOTOS: First look at new hotel set to replace former Humana tower in downtown Louisville - WHAS11
Jefferies Maintains Buy Rating on Humana (HUM) but Lowers Price Target | HUM Stock News - GuruFocus
Humana (HUM): UBS Lowers Price Target, Maintains Neutral Rating - GuruFocus
Renderings revealed: Humana Building's transformation into 1,000-room hotel - The Business Journals
Mayor Craig Greenberg shares renderings for the Humana Tower’s hotel transformation - WAVE News
PHOTOS: First look at renderings of big Humana Tower renovation - WLKY
RBC Capital Downgrades Humana (HUM): Price Target Slashed | HUM Stock News - GuruFocus
Humana Analysts Slash Their Forecasts After Q4 Results - Benzinga
Guggenheim Lowers Price Target for Humana (HUM) but Maintains Bu - GuruFocus
Humana's Higher Membership Growth Could Put Medicare Advantage Book at Risk, RBC Says - marketscreener.com
Morgan Stanley Sees Humana’s Earnings Recovery Taking Longer - Finimize
Humana Earnings Recovery Under Threat From Multiple Headwinds, Morgan Stanley Says - marketscreener.com
Cantor Fitzgerald lowers Humana stock price target to $201 from $290 - Investing.com
Oppenheimer Adjusts Humana Price Target to $250 From $310, Maintains Outperform Rating - marketscreener.com
Humana Guides 2026 EPS to $9, Shares Drop 6.5% - GuruFocus
Cantor Fitzgerald Cuts Humana (NYSE:HUM) Price Target to $201.00 - MarketBeat
Evercore ISI Cuts Humana (NYSE:HUM) Price Target to $180.00 - MarketBeat
Leerink Partners Lowers Humana (NYSE:HUM) Price Target to $185.00 - MarketBeat
Humana forecasts 2026 profit pressure as lower quality ratings weigh - MSN
Humana stock rating downgraded by RBC Capital on Medicare Advantage risk - Investing.com India
Guggenheim lowers Humana stock price target on Stars headwind concerns By Investing.com - Investing.com India
Humana Inc. (NYSE:HUM) Q4 2025 earnings call transcript - MSN
Guggenheim lowers Humana stock price target on Stars headwind concerns - Investing.com
Humana Inc. (NYSE:HUM) Q4 2025 Earnings Call Transcript - Insider Monkey
HUM Downgraded by RBC Capital Amid Concerns Over Membership Grow - GuruFocus
Morgan Stanley Cuts Price Target on Humana to $146 From $174, Keeps Underweight Rating - marketscreener.com
Jefferies Adjusts Price Target on Humana to $235 From $310, Maintains Buy Rating - marketscreener.com
RBC Downgrades Humana to Sector Perform From Outperform, Cuts Price Target to $189 From $322 - marketscreener.com
Is Humana Stock Built to Withstand More Downside? - Trefis
Humana's Q4 loss widens - Insurance Business
Humana could end 2026 as the largest Medicare Advantage insurer - Healthcare Dive
Humana (HUM) Net Margin Stuck Near 1% Keeps Long Term Growth Narratives Under Scrutiny - simplywall.st
Humana Earnings Call: Growth Prospects Versus STARS Hit - TipRanks
Humana stock price target lowered to $180 from $260 at Evercore ISI - Investing.com India
Humana (HUM) Shares Decline Despite Strong Earnings and Membersh - GuruFocus
Humana Q4 Earnings Call Highlights - MarketBeat
Humana (HUM) Projects Strong Growth in 2026 with Strategic Initiatives - GuruFocus
Humana sells Hikes Lane medical office building for $2.5M - The Business Journals
Humana Inc (HUM) Q4 2025 Earnings Call Highlights: Strong EPS Pe - GuruFocus
Humana Incurs Q4 Loss, Revenues Up Y/Y on CenterWell Unit Strength - Yahoo Finance
Humana Profits Falling as Medicare Advantage Membership Surges - Morningstar
Humana (NYSE:HUM) Shares Gap DownTime to Sell? - MarketBeat
Humana CEO: Insurer is ready to adapt if 2027 MA rates stay flat - Fierce Healthcare
Humana projects sharply lower earnings as Medicare membership surges - statnews.com
Humana’s 2026 Profit Outlook Takes A Hit From Star Ratings - Finimize
Humana Inc Stock (HUM) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.09%
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):